SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1.35 |
| Enterprise Value ($M) | 62.84 |
| Book Value ($M) | 70.05 |
| Book Value / Share | 21.53 |
| Price / Book | 0.02 |
| NCAV ($M) | 68.07 |
| NCAV / Share | 20.92 |
| Price / NCAV | 0.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.14 |
| Return on Assets (ROA) | -1.67 |
| Return on Equity (ROE) | -3.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.34 |
| Current Ratio | 5.34 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 83.84 |
| Assets | 85.82 |
| Liabilities | 15.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,281 | 49,514 | 4.61 | |
| 2,051 | 21,528 | 9.53 | |
| 4,351 | 78,373 | 5.55 | |
| 29,558 | 93,763 | 31.52 | |
| 25,807 | 144,384 | 17.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELUT – Elutia Inc. | ENLV – Enlivex Therapeutics Ltd. |
| ENSC – Ensysce Biosciences, Inc. | ENTX – Entera Bio Ltd. |
| ENVB – Enveric Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io